Hetastarch in Sodium Chloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Hetastarch.
Product ID | 0409-7248_472468e6-3ee8-444d-98ba-3ebaab2303af |
NDC | 0409-7248 |
Product Type | Human Prescription Drug |
Proprietary Name | Hetastarch in Sodium Chloride |
Generic Name | Hetastarch |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2005-02-28 |
Marketing Category | ANDA / ANDA |
Application Number | BA740193 |
Labeler Name | Hospira, Inc. |
Substance Name | HETASTARCH |
Active Ingredient Strength | 6 g/100mL |
Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2005-02-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | BA740193 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-02-28 |
Marketing Category | ANDA |
Application Number | BA740193 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-07-07 |
Marketing Category | ANDA |
Application Number | BA740193 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-02-28 |
Marketing End Date | 2018-05-01 |
Marketing Category | ANDA |
Application Number | BA740193 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-05-26 |
Marketing End Date | 2018-05-01 |
Ingredient | Strength |
---|---|
HETASTARCH | 6 g/100mL |
SPL SET ID: | d64f961a-3e1f-4b04-cf83-604474af2775 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-7248 | Hetastarch in Sodium Chloride | HETASTARCH |
0264-1965 | HESPAN | Hetastarch in Sodium Chloride |
0409-1555 | Hextend | HETASTARCH |